Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare diseases, many of which are genetic […] ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

To share your story, or find out how to get involved with CNBC Cures, email [email protected] Florida state Rep. Adam Anderson championed the Sunshine Genetics Act, the first state-backed genetic ...

Genetic tests make up a growing share of total spending on laboratory tests under Medicare Part B, according to a report posted last week by the Department of Health and Human Services’ Office of ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation misses on earnings expectations. Reported EPS is $-0.49946 EPS, expectations ...

Precision Medicine Online and My Gene Counsel have partnered since 2019 on the "Genetic Testing Challenges" series to highlight real-world issues medical professionals are encountering as genetic ...

The Australian government has introduced legislation that will prevent life insurance companies from using adverse genetic test outcomes in their underwriting processes. The legislative proposal ...